- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Posted on 3/23/26 at 3:15 pm to ApexHunterNetcode
Is this thing ever gonna come back? 
Posted on 3/24/26 at 4:38 am to Neauxla
This is why i laugh these days when people say never sell. So if you bought at 400 or 500 you have to be rethinking this strategy. 
Posted on 3/24/26 at 6:51 am to FLObserver
quote:
This is why i laugh these days when people say never sell. So if you bought at 400 or 500 you have to be rethinking this strategy.
Because of ESPP over the years, 15% off the lower of the six-month Jan/Jun low, I acquired a significant amount over the years. Basis is $219 currently, so still have significant gains overall. Have sold off several sizable blocks over the years.
UNH’s 2-year high is essentially the same range — around the mid-$550s.
UnitedHealth peaked in that zone before the 2024–2025 selloff tied to Change Healthcare fallout and reimbursement pressure.
Right now, most analytic sites have it as a "Hold", with an upside range to $368,50 ( Tip Ranks) Targets range from $311 on the low end to $440 on the high end.
In my case, I didn't sell when it topped $600 although I started to think seriously about it. Issue was capital gains tax and IRMAA impact.
Nobody could have foreseen the Change Healthcare cyber-attack or the CMS reimbursement pressure. Rear view mirror stuff.
It's still the "gold standard" of healthcare companies and Hemsley is a very solid CEO. Just have to level set expectations.
Posted on 4/6/26 at 9:17 pm to Nole Man
Hate to disagree but will. Today’s after hours pop is tied to the MA rate notice from CMS. The underlying fundamentals are still not strong in the Medicare Advantage business. In fact they have outsized exposure to risk scores and the notice today essentially delays impact by a year. The earnings call on 4/21 will be important to watch.
For the record I still hold some UNH but will likely use this pop to sell off some and buy alignment health instead.
For the record I still hold some UNH but will likely use this pop to sell off some and buy alignment health instead.
Posted on 4/8/26 at 7:40 am to CaptainJ47
Trying to decide if I should sell today or not. About back to my original investment and maybe I should put that $ elsewhere
Posted on 4/8/26 at 8:57 pm to Neauxla
The long term view on MA isn’t great, particularly UNH and HUM. The 2027 payment rule gave them a reprieve so I sold the pop. The 2028 rule will likely crush those two in the MA space. I was actually quoted in modern healthcare today about the rule so it is the space I am passionate about. The room to run may be there a bit and I am anxious to see Q1 earnings, but I am out for now.
Posted on 4/9/26 at 8:26 am to CaptainJ47
Do you think providers are finally going to get a boost after 20 years? Noticed and small up tick in E&M codes, but way behind inflation over the last two decades and ancillaries were slashed. Trying to decide if I just want to go all in on industrial medicine and switch to urgent care/direct primary care or try to keep traditional system in place to be able and keep more of my long term patients.
Posted on 4/9/26 at 6:57 pm to SmackoverHawg
My team got asked to do an education for a large entity in Georgia about this exact topic. Providers do get a tick up but frankly it is small. The 20 year trend relative to inflation for providers sucks. Providers, especially independents, are in a tough spot.
I am seeing a lot of orgs move from value based care back to fee for service. Beckers maintains a list of those orgs.
That said, I do think the incentive structure in 2028 and beyond does start to shift harder to outcomes based on CMS guidance. Not good for big payers but signs that healthcare has to bend the cost curve. Providers are just stuck in the damn machine.
I assume you are in Arkansas?
I am seeing a lot of orgs move from value based care back to fee for service. Beckers maintains a list of those orgs.
That said, I do think the incentive structure in 2028 and beyond does start to shift harder to outcomes based on CMS guidance. Not good for big payers but signs that healthcare has to bend the cost curve. Providers are just stuck in the damn machine.
I assume you are in Arkansas?
Posted on 4/9/26 at 8:57 pm to CaptainJ47
Yep. Looks like I'll be shifting my practice away from patient care to industrial medicine.
Posted on 4/14/26 at 10:45 am to SmackoverHawg
Finally got out of this thing and now I just need Trump to do something stupid so I can buy something on a dip.
Posted on 4/21/26 at 8:15 am to Neauxla
Looks like we are back in action!
Posted on 4/21/26 at 12:10 pm to lsuconnman
Currently:
$350.56 / 8.37% / +$27.07 Today
UnitedHealth Group UNH 8.61%increase; green up pointing triangle reported first-quarter results that substantially overshot Wall Street expectations and raised its annual guidance, signaling progress in its financial turnaround.
The announcement is likely to build investor confidence in the healthcare company’s current direction, a year after UnitedHealth announced an earnings shortfall that touched off an unprecedented share meltdown for the company.
Wall Street Darling Returns!
$350.56 / 8.37% / +$27.07 Today
UnitedHealth Group UNH 8.61%increase; green up pointing triangle reported first-quarter results that substantially overshot Wall Street expectations and raised its annual guidance, signaling progress in its financial turnaround.
The announcement is likely to build investor confidence in the healthcare company’s current direction, a year after UnitedHealth announced an earnings shortfall that touched off an unprecedented share meltdown for the company.
Wall Street Darling Returns!
Posted on 4/21/26 at 4:23 pm to Nole Man
got back in at 265. Hopefully a nice ride back up to the 400's while collecting that div. 
Posted on 4/21/26 at 5:06 pm to CaptainJ47
I totally agree with everything you are saying on the MA space. I'm curious your opinion on a few questions:
1. Is there potential for the MA space to rebound in future years?
2. what about the other 75% of UNH's revenue. Does that have a stronger outlook?
3. Do you think Oscar Health has legit room for growth considering the MA envinroment?
1. Is there potential for the MA space to rebound in future years?
2. what about the other 75% of UNH's revenue. Does that have a stronger outlook?
3. Do you think Oscar Health has legit room for growth considering the MA envinroment?
Posted on 4/21/26 at 8:09 pm to 314stunna
So globally I am intrigued by the move here today. The number one thing I was surprised by that moved the stock was the medical loss ratio. If you look at it that will tell you a ton about the stock, lower is better. What is hard to tell here is why. UHC has started rotating back to fee for service in commercial and decreased their MA lives. That is fascinating to me and contrary to their Optum Health portfolio.
Speaking of Optum, all of their business segments are down in margin and flat in growth. Optum has made up a tremendous portion of growth the last few years. That seems to be over and in fact a sale of an unknown asset in the Uk created favorable margins in Optum or the picture would be worse.
To your questions
1) MA margins will remain compressed because hospital billing is getting stronger with new technology. It will create denials by UHC. Health systems will then fight this by leaving networks- see California. I do think UHC and MA stabilize but it isn’t a growth engine anymore.
2) What is interesting is UHC forecasts erosion in their customers served. This quarter their lives were higher than expected. Overall lives dropped by 1M yet premiums were higher. A lot of losses in lives in MA where premiums per patient are the higher. I am honestly amazed at the pricing power for the commercial side. To me that area has outperformed.
3) Interestingly enough I rarely see much of Oscar at my health system clients. I really don’t have a ton of opinions on them right this second.
Speaking of Optum, all of their business segments are down in margin and flat in growth. Optum has made up a tremendous portion of growth the last few years. That seems to be over and in fact a sale of an unknown asset in the Uk created favorable margins in Optum or the picture would be worse.
To your questions
1) MA margins will remain compressed because hospital billing is getting stronger with new technology. It will create denials by UHC. Health systems will then fight this by leaving networks- see California. I do think UHC and MA stabilize but it isn’t a growth engine anymore.
2) What is interesting is UHC forecasts erosion in their customers served. This quarter their lives were higher than expected. Overall lives dropped by 1M yet premiums were higher. A lot of losses in lives in MA where premiums per patient are the higher. I am honestly amazed at the pricing power for the commercial side. To me that area has outperformed.
3) Interestingly enough I rarely see much of Oscar at my health system clients. I really don’t have a ton of opinions on them right this second.
Posted on 4/21/26 at 9:11 pm to CaptainJ47
The number one thing I was surprised by that moved the stock was the medical loss ratio. If you look at it that will tell you a ton about the stock, lower is better.
MLR is nothing more than audit gamesmanship. If it’s too low the plans get penalized, so they have to be clever to keep it over a stated percentage.
It’s remarkable how you can have multibillion dollar plans with hundreds of variables, but you can look at a five year audit and discover the MLR miraculously sat at 85.1% every single year. The real magic for heath plans is the retroactive fraud/waste/abuse audits and denying services billed by providers…but not removing them out from the MLR numbers.
MLR is nothing more than audit gamesmanship. If it’s too low the plans get penalized, so they have to be clever to keep it over a stated percentage.
It’s remarkable how you can have multibillion dollar plans with hundreds of variables, but you can look at a five year audit and discover the MLR miraculously sat at 85.1% every single year. The real magic for heath plans is the retroactive fraud/waste/abuse audits and denying services billed by providers…but not removing them out from the MLR numbers.
Posted on 4/22/26 at 6:22 am to lsuconnman
Oh it is absolutely a level of gamesmanship on the MLR. Look at every other facet of their earnings. Revenue overall barely ticked up, intentionally in all likelihood given some of the MA population losses, margins ticked down, and Optum is struggling.
The MLR was the first positive blip in quarters I believe. I am still interested in understanding more of how that occurred and if it is population mix or something more material.
The MLR was the first positive blip in quarters I believe. I am still interested in understanding more of how that occurred and if it is population mix or something more material.
Popular
Back to top


1




